Enhancing mesenchymal stromal cell potency: inflammatory licensing via mechanotransduction

HIGHLIGHTS

  • who: Max A. Skibber from the Department of Pediatric Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, At Houston, Houston, TX, United States have published the Article: Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction, in the Journal: (JOURNAL)
  • what: This study builds on the previous work by investigating how a range of physiologic WSS magnitudes Frontiers in Immunology | www.frontiersin.org affect the prospective cell therapy`s clinical translatability in a bioreactor scaled up for research purposes. The authors demonstrate a dose-dependence of mesenchymal stromal cells` antiinflammatory potential . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?